Table 2 Acute coronary syndrome management according to all ACS, STEMI or UA/NSTEMI
| Â | All ACS (n= 566) | STEMI (n=146) | UA/NSTEMI (n=420) | p |
|---|---|---|---|---|
| Â | Â |
| Â | |
Duration between chest pain onset and ED arrival : median (IQR) (hour) | 2 (1-4) | 2 (1-3) | 2 (1-4) | 0.000 |
Duration between ED admission and treatment starting: median (IQR) (hour) | 3 (1-11) | 2 (0.33-8.7) | 4 (1.12-12.5) | 0.000 |
ED length of stay: median (IQR) | 6 (2.75-16) | 2 (0.5-5) | 8 (4-20) | 0.000 |
Medications | ||||
β blockers | 66 (14.6) | 4 (3.6) | 62 (18.1) | 0.000 |
 Converting enzyme inhibitors | 82 (18.3) | 11 (9.9) | 71 (21.0) | 0.009 |
In hospital management of ACS | ||||
Thrombolysis n (%) | 41 (7.2)* | 37Â (25.3)** | 4 (0.95) | 0.000 |
 Streptokinase | 21 | 19 | 3 |  |
 Alteplase | 20 | 18 | 1 |  |
Administered treatment: n (%) | ||||
 Aspirin | 499 (91.9) | 133 (97.1) | 366 (90.1) | 0.010 |
 Clopidogrel | 392 (74.1) | 124 (89.9) | 268(68.5) | 0.000 |
 LMWH (HNF) | 254 (49.9) | 84 (64.6) | 170 (44.9) | 0.000 |
Outcomes | ||||
 MACE | 63(11.1) | 27 (20.0) | 36 (9.1) | 0.001 |
  Deaths | 7 | 3 | 4 | 0.27 |
  Cardiogenic shock | 8 | 4 | 4 | 0.09 |
  Acute Pulmonary Oedema | 43 | 15 | 28 | 0.11 |
  Arrhythmia | 18 | 12 | 6 | 0.000 |
  Others (conduction disorders) | 9 | 7 | 2 | 0.26 |
 Transfer to Cardiology Intensive Care Unit | 269 | 108 (73.9) | 161 (38.3) | 0.000 |
